Ignite Creation Date:
2025-12-24 @ 9:42 PM
Ignite Modification Date:
2026-05-31 @ 6:07 PM
Study NCT ID:
NCT05312632
Status:
COMPLETED
Last Update Posted:
2024-09-23
First Post:
2022-03-28
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Efficacy and Safety of Safinamide Mesilate as Add-on Therapy to Levodopa in Parkinson's Disease Participants With Motor Fluctuation in South Korea
Sponsor:
Eisai Korea Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Parkinson Disease | View |
Keywords: